Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03821064 · ClinicalTrials.gov registry record · NA
Single-arm Phase II Study of NDURE for Patients With HNC
A NA study of Cancer of Head and Neck, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT03821064: Completed NA study of Cancer of Head and Neck, sponsored by Medical University of South Carolina.
NCT03821064 is a NA study of Cancer of Head and Neck that has completed, run by Medical University of South Carolina. The registered enrollment target is 11 participants, below the 248-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03821064, a NA study of Cancer of Head and Neck, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate whether a new patient navigation intervention can decrease delays starting post-operative radiation therapy after surgery for white and African-American head and neck cancer patients.
Primary Outcome
Percent of patients who start PORT \>6 weeks after surgery. Initiation of postoperative PORT \> 6 weeks after surgery is defined as more than 42 calendar days from the time of the definitive surgical resection to the initiation of radiation therapy. In situations in which the surgical management of the primary tumor and the neck are staged (i.e. occur on two different calendar days), the date of the surgery for the primary tumor will be used. In situations in which an additional surgical resecti
Conditions Studied
Interventions
- OTHER Patient Navigation
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-06-03 |
| Est. Completion | 2019-11-21 |
| Phase | NA |
What the finished NCT03821064 record still lists
NCT03821064 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 248-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Cancer of Head and Neck appearing as the primary indexed condition, and to 1 intervention - of which Patient Navigation is the first listed.
NCT03821064 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT03821064 about?
NCT03821064 is a clinical study titled "Single-arm Phase II Study of NDURE for Patients With HNC". This study will evaluate whether a new patient navigation intervention can decrease delays starting post-operative radiation therapy after surgery for white and African-American head and neck cancer patients.
What is the current status of trial NCT03821064?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2019-06-03. Estimated completion is 2019-11-21.
What conditions does trial NCT03821064 study?
This clinical trial studies the following conditions: Cancer of Head and Neck.
What interventions are being tested in trial NCT03821064?
The interventions under investigation include: Patient Navigation (OTHER).
Who is sponsoring clinical trial NCT03821064?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03821064 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer of Head and Neck
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03821064's enrollment target sits among peer trials
11 7th of 9 higher than 2 of 9 other Cancer of Head and Neck trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer of Head and Neck trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Comprehensive Approach to Head and Neck Cancer Prehabilitation
ACTIVE NOT RECRUITING · NA
-
Onco-primary Care Networking to Support TEAM-based Care
ACTIVE NOT RECRUITING · NA
-
Adaptive Radiation Therapy for Head & Neck Cancer Patients
COMPLETED · NA
-
The Gut Microbiome As an Indicator of Readiness for Head & Neck Cancer Surgery
COMPLETED · NA
-
Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers
COMPLETED · NA
-
A Multicenter Cancer Biospecimen Collection Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI